CTD Holdings Receives Rare Pediatric Disease Designation for Trappsol(R) Cyclo(TM)
ALACHUA, FL--(Marketwired - December 06, 2017) - CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease with unmet medical need, today announced that it has received …